Overview

Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France

Status:
Completed
Trial end date:
2018-09-27
Target enrollment:
Participant gender:
Summary
The purpose of the study is to describe the characteristics and management of post menopausal women with osteoporosis treated with Prolia in France, and examine the use of Prolia in routine clinical practice in France
Details
Lead Sponsor:
Amgen
Treatments:
Denosumab